Note 17 - Earnings Per Share (Tables)

9 Months Ended

Mar. 31, 2026

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended					Nine Months Ended
	March 31,					March 31,
	2026			2025		2026			2025
	(in thousands, except share and per share data)
BASIC
Numerators:
Net (loss) income from continuing operations	$	(5,618	)	$	3,940	$	(14,237	)	$	5,698
Net income from discontinued operations, net of tax		—			54		—			558
Net (loss) income	$	(5,618	)	$	3,994	$	(14,237	)	$	6,256
Denominator:
Basic weighted-average common shares outstanding		10,511,583			6,134,634		9,992,577			6,111,550
Basic per share calculations:
Net (loss) income per share from continuing operations	$	(0.53	)	$	0.64	$	(1.42	)	$	0.93
Net income per share from discontinued operations, net of tax	$	—		$	0.01	$	—		$	0.09
Net (loss) income per share	$	(0.53	)	$	0.65	$	(1.42	)	$	1.02

	Three Months Ended					Nine Months Ended
	March 31,					March 31,
	2026			2025		2026			2025
	(in thousands, except share and per share data)
DILUTED
Numerators:
Adjusted numerator - net (loss) income from continuing operations (1)	$	(5,618	)	$	1,679	$	(14,237	)	$	(2,459	)
Net income from discontinued operations, net of tax		—			54		—			558
Net (loss) income	$	(5,618	)	$	1,733	$	(14,237	)	$	(1,901	)
Denominator:
Basic weighted-average common shares outstanding		10,511,583			6,134,634		9,992,577			6,111,550
Dilutive effect of warrants to purchase common stock		—			2,060,510		—			2,482,368
Dilutive effect of unvested restricted stock and restricted stock units		—			9,309		—			12,095
Diluted weighted-average common shares outstanding		10,511,583			8,204,453		9,992,577			8,606,013
Diluted per share calculations:
Net (loss) income per share from continuing operations	$	(0.53	)	$	0.20	$	(1.42	)	$	(0.29	)
Net income per share from discontinued operations, net of tax	$	—		$	0.01	$	—		$	0.06
Net (loss) income per share	$	(0.53	)	$	0.21	$	(1.42	)	$	(0.22	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2026		2025		2026		2025
Warrants to purchase common stock - liability classified (note 16)		2,190,681		3,821,256		2,190,681		3,399,398
Warrants to purchase common stock - equity classified (note 16)		1,630,434		15,571		1,630,434		15,571
Weighted-average of warrants exercised to common stock (note 16)		—		—		478,921		—
Outstanding stock options (note 15)		203,744		219,244		203,744		219,244
Unvested restricted stock (note 15)		220,304		25,223		220,304		22,437
Unvested restricted stock units (note 15)		—		84		—		84
Total anti-dilutive securities		4,245,163		4,081,378		4,724,084		3,656,734